Your browser doesn't support javascript.
loading
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
Chua, Brendon Y; Sekiya, Toshiki; Koutsakos, Marios; Nomura, Naoki; Rowntree, Louise C; Nguyen, Thi H O; McQuilten, Hayley A; Ohno, Marumi; Ohara, Yuki; Nishimura, Tomohiro; Endo, Masafumi; Itoh, Yasushi; Habel, Jennifer R; Selva, Kevin J; Wheatley, Adam K; Wines, Bruce D; Hogarth, P Mark; Kent, Stephen J; Chung, Amy W; Jackson, David C; Brown, Lorena E; Shingai, Masashi; Kedzierska, Katherine; Kida, Hiroshi.
Affiliation
  • Chua BY; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE) Hokkaido University, Sapporo, Japan.
  • Sekiya T; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Koutsakos M; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE) Hokkaido University, Sapporo, Japan.
  • Nomura N; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Rowntree LC; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Nguyen THO; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • McQuilten HA; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Ohno M; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Ohara Y; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nishimura T; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Endo M; International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Itoh Y; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Habel JR; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Selva KJ; KM Biologics Co. Ltd., Kumamoto, Japan.
  • Wheatley AK; Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
  • Wines BD; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Hogarth PM; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kent SJ; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Chung AW; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
  • Jackson DC; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia.
  • Brown LE; Department of Pathology, The University of Melbourne, Parkville, Australia.
  • Shingai M; Immune Therapies Group, Burnet Institute, Melbourne, Australia.
  • Kedzierska K; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Australia.
  • Kida H; Department of Pathology, The University of Melbourne, Parkville, Australia.
PLoS Pathog ; 18(10): e1010891, 2022 10.
Article in En | MEDLINE | ID: mdl-36206307

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2022 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS Pathog Year: 2022 Document type: Article Affiliation country: Japón